Download presentation
Presentation is loading. Please wait.
Published byCollin Reynolds Modified over 6 years ago
1
Figure 2 Kaplan–Meier estimates of event-free survival (survival to the combined endpoint).
From: Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial Eur Heart J. 2007;28(6): doi: /eurheartj/ehl535 Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please
2
Figure 1 Flow scheme of the follow-up in both groups.
From: Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial Eur Heart J. 2007;28(6): doi: /eurheartj/ehl535 Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please
3
Figure 3 Kaplan–Meier estimates of overall survival (survival to death from any cause).
From: Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial Eur Heart J. 2007;28(6): doi: /eurheartj/ehl535 Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please
4
Figure 4 Late mortality among 30 day survivors (day 31—end of follow-up) on top of early (day 1–30) mortality among all randomized patients. From: Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial Eur Heart J. 2007;28(6): doi: /eurheartj/ehl535 Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.